Corporate Overview

A Center of Excellence for What We Do

Everest Clinical Research ("Everest") is a full-service contract research organization (CRO) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. We serve some of the best-known companies and work with many of the most advanced drugs, biologics, and medical devices in development today.

Everest has been a CRO since January 2004 with a strong foundation as a statistical, programming, and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Headquartered in Toronto, Canada, with subsidiary offices in New Jersey, USA; Shanghai, China; Taipei, Taiwan; Bulgaria, Romania, Poland, and Croatia in Europe. Everest continues to deepen capabilities and serve highly satisfied customers in data/analytics services and full-service execution with quality, effectiveness, and agility for worldwide clinical trials.

Growing steadily over 21 years, Everest is a preferred vendor for 100+ active clients, including major, mid-sized, and small pharmaceutical, biotech, and medical device companies. We value our clients and all growth to date is primarily from their repeat and referral business. We are known for our high-touch approach with client teams, high quality standards, customer-focus, “can-do” culture, advanced technology utilization, and continuous improvement. A dynamic organization with an entrepreneurial origin, Everest continues to experience exceptional growth and great success.

Quality is our backbone, customer-focus is our tradition, flexibility is our strength...that’s us…that’s Everest.

Our Mission and Story

Our mission is to provide outstanding quality, on-time delivery, and exceptional customer service to our clinical research partners.

Company Highlights

  • Created by a group of former colleagues of Pharmacia Corporation, Everest has been an independent CRO since 2004 following Pfizer’s acquisition of Pharmacia.
  • Successfully operating for over 21 years as an independent CRO, building preferred vendor relationships with a list of global major pharmaceutical companies and over 90 mid-sized and small pharmaceutical, biotechnology, and medical device companies.
  • In December 2022, Everest acquired Brightech International, a New Jersey-based CRO that specializes in Biometrics services. Brightech was founded in 2004 and successfully operated for over 19 years as an independent CRO prior to Everest’s acquisition.
  • In November 2023, Everest acquired August Research, a European CRO that provides Clinical Operations and Pharmacovigilance services to a wide variety of pharmaceutical and biotechnology clients. August Research has its corporate headquarters located in Sofia Bulgaria, with clinical operations capabilities in North America, Eastern and Western European countries. August Research was founded in 2012 and successfully operated for over 11 years as an independent CRO prior to Everest’s acquisition.
  • Growing steadily over 21 years, Everest is a preferred vendor for 100+ active clients.
  • A growing company with over 700 full-time staff members and a resource pool of part-time and contract-based consultants.
  • All company growth to date is primarily based on repeat and referral business from our satisfied clients.
  • Known for a high-touch approach with client teams, high quality standards, customer-focus, “can-do” culture, utilizing advanced technologies, and continuous improvement.
  • A proven history of stable workforce through high quality standards for talent recruitment and strong staff retention measures.
  • Offers quality and timely services at competitive rates.
  • Continues to deepen capabilities and serve highly satisfied customers in data/analytics services and full-service execution with quality, effectiveness, and agility for conducting worldwide clinical trials.

Latest News

Markham office

Everest Clinical Research Announces Key Leadership Appointments to Drive Continued Growth

bgr2

Press Release – Acquisition of August Research

iStock-157647709

Press Release – Acquisition of Brightech International

iStock-1163919598

Access clinical trial data visualizations through our Clinical Data Dashboard

iStock-510463331

We are ready for an accelerated growth in 2021 and years beyond!

Are you ready to get started?

Tell us about your next project